Historically, hop cones (Humulus lupulus) have been used since ancient times as a remedy for many ailments and, as a source of polyphenols and bitter acids, is very effective in the treatment of metabolic syndrome (MS). Hop flavonoids, particularly xanthohumol (XN), are substances with hypoglycemic, antihyperlipidemic, and antiobesity activities. Iso-α-acids (IAA) and matured hop bitter acids (MHBA) improve health by influencing lipid metabolism, glucose tolerance, and body weight. The modulatory effect of IAA and MHBA on lipid metabolism may also be responsible for a loss in body weight. These results suggest promising applications for IAA, MHBA, and XN in humans, particularly in the prevention of diet-induced obesity and diabetes.
Hop Phytochemicals and Their Potential Role in Metabolic Syndrome Prevention and Therapy
P. Dostálek,M. Karabín,L. Jelínek
Published 2017 in Molecules
ABSTRACT
PUBLICATION RECORD
- Publication year
2017
- Venue
Molecules
- Publication date
2017-10-01
- Fields of study
Medicine, Chemistry, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-88 of 88 references · Page 1 of 1
CITED BY
Showing 1-63 of 63 citing papers · Page 1 of 1